Director Mel Gibson’s “Flight Risk,” starring Mark Wahlberg, is new in theaters. Does the airplane thriller have a smooth or bumpy landing with critics?

Haven’t we suffered enough? Beyond all the chaos happening right now in the political sphere, there’s a new Mel Gibson movie in cinemas. Yes, the relentlessly hateful Mel Gibson, the once-celebrated Hollywood legend (and two-time Oscar winner),

Mark Wahlberg shared how his wife Rhea Durham reacted after he shaved his head to play his balding character in Mel Gibson's new movie "Flight Risk."

After watching Mel Gibson's latest movie, Flight Risk, which stars Mark Wahlberg, Michelle Dockery, and Topher Grace, it makes sense why Lionsgate moved it to a January 2025 release.

"Flight Risk"—director Mel Gibson’s new action thriller starring Mark Wahlberg—is targeting a No. 1 debut at the weekend box office.

Flight Risk, the new Mel Gibson directorial outing, is a similar kind of tale, following characters trapped in a dangerously small plane with even more of a dangerous man. Some elements and moments are effective,

Michelle Dockery and Topher Grace also star in this movie about a U.S. Marshall, her mob-connected witness and a hit man posing as a pilot.

Mel Gibson returned to filmmaking after almost a decade with Flight Risk. The film opened in the theatres on Friday and has earned a decent number on opening day. The movie remained below Den of Thieves 2: Pantera’s release day collection. Keep scrolling for more.

Mel Gibson, the cinematic maverick known for his explosive action sequences and controversial persona, takes the helm once again in “Flight Risk,” a white-knuckle thriller set almost entirely

Mark Wahlberg stars in the action-thriller, which marks the first film Gibson has directed in nearly a decade.

A big deal is made about the work scientists and doctors are doing to delay or prevent age-related diseases, but Dr. Andrew Steele says he was turned down — and blocked on Twitter — when he suggested Johnson use some of his hundreds of millions of dollars to fund a clinical trial to prove the effects of one of the drugs he was already taking.